Results 111 to 120 of about 70,197 (213)

Efficacy of antituberculosis therapy in combination with antiretroviral therapy in patients with co-infection TB/HIV [PDF]

Medičnì Perspektivi, 2013
Changes towards worsening of epidemiologic situation as for tuberculosis in a great extent are caused by spread of HIV-infection among population of Ukraine.
Kryzhanovsky D.G., Marchenko N.A.
doaj  

Miopericarditis como complicación cardiovascular en la infección por VIH.

Revista GICOS, 2021
Introducción: Las complicaciones cardiovasculares son actualmente una causa principal de morbilidad y mortalidad en la población infectada por el Virus de Inmunodeficiencia Humana (VIH), sobre todo en los países subdesarrollados.
Luis Dulcey, Jonathan Pineda, José Sampayo, Raimondo Caltagirone   +3 more
doaj  

In vivo anti-HIV activity of the heparin-activated serine protease inhibitor antithrombin III encapsulated in lymph-targeting immunoliposomes.

PLoS ONE, 2012
Endogenous serine protease inhibitors (serpins) are anti-inflammatory mediators with multiple biologic functions. Several serpins have been reported to modulate HIV pathogenesis, or exhibit potent anti-HIV activity in vitro, but the efficacy of serpins ...
Mohammed Asmal, James B Whitney, Corinne Luedemann, Angela Carville, Robert Steen, Norman L Letvin, Ralf Geiben-Lynn   +6 more
doaj   +1 more source

Integrating Flow Cytometry in the Diagnostic Work of HIV‐Associated Hodgkin's Lymphomas

Journal of Cellular and Molecular Medicine, Volume 30, Issue 9, May 2026.
ABSTRACT Hodgkin lymphoma (HL) is prevalent worldwide and typically presents symptoms like sudden pain, swelling, and weight loss. Classical HL (cHL) is largely treatable with modern risk‐adapted and response‐based therapy. cHL represents one of the most common malignancies occurring during the course of evolution in patients living with HIV.
Maria Santa, Diana Cenariu, Adrian‐Bogdan Tigu, Marc Damian, Patricia Rantshabeng, Tendani Gaolathe, Andrew K. Ndlovu, Khalid Abdelrahman, Madalina Nistor, David Kegyes, Diana Gulei, Cristian Jinca, Anamaria Bancos, Ioana Rus, Horia Bumbea, Victor Tomacinschii, Sanda Buruiana, Rand Bilal, Cristina Selicean, Mihnea Zdrenghea, Bogdan Fetica, Cristina Stefan, Jonathan Fromm, Ciprian Tomuleasa   +23 more
wiley   +1 more source

Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trial

Journal of Virus Eradication
Objective: Antiretroviral therapy (ART)-conferred suppression of HIV replication limits neuronal injury and inflammation. ART interruption tests efficacy in HIV cure trials and viral rebound after ART interruption may induce neuronal injury.
Jasmini Alagaratnam, Wolfgang Stöhr, Elizabeth Hamlyn, Kholoud Porter, Jamie Toombs, Amanda Heslegrave, Henrik Zetterberg, Magnus Gisslén, Jonathan Underwood, Mauro Schechter, Pontiano Kaleebu, Giuseppe Tambussi, Sabine Kinloch, Jose M. Miro, Anthony D. Kelleher, Abdel Babiker, John Frater, Alan Winston, Sarah Fidler   +18 more
doaj   +1 more source

In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I Metabolites.

PLoS ONE, 2015
Cancer cells have a high iron requirement and many experimental studies, as well as clinical trials, have demonstrated that iron chelators are potential anti-cancer agents.
Eliška Potůčková, Jaroslav Roh, Miloslav Macháček, Sumit Sahni, Ján Stariat, Vít Šesták, Hana Jansová, Pavlína Hašková, Anna Jirkovská, Kateřina Vávrová, Petra Kovaříková, Danuta S Kalinowski, Des R Richardson, Des R Richardson, Tomáš Šimůnek   +14 more
doaj   +1 more source

Defining and Predicting HIV Immunological Non-Response: A Multi-Definition Analysis from an Indonesian Cohort

Viruses
Immunological non-response (INR) to antiretroviral therapy (ART) is a critical concern for PLHIV, characterized by inadequate CD4+ T-cell recovery despite virological suppression.
Brian Eka Rachman, Yehuda Tri Nugroho Supranoto, Soraya Isfandiary Iskandar, Tri Pudy Asmarawati, Siti Qamariyah Khairunisa, Muhammad Vitanata Arfijanto, Usman Hadi, Muhammad Miftahussurur, Nasronudin Nasronudin, Masanori Kameoka, Retno Pudji Rahayu, Afif Nurul Hidayati   +11 more
doaj   +1 more source

Utilização dos registros de dispensação da farmácia como indicador da não-adesão à terapia anti-retroviral em indivíduos infectados pelo HIV Pharmacy records as an indicator of non-adherence to antiretroviral therapy by HIV-infected patients

Cadernos de Saúde Pública, 2009
Este estudo teve como objetivos avaliar os registros de dispensação de anti-retrovirais (ARV) por um período de 12 meses após a primeira prescrição e determinar os fatores associados com a retirada irregular ou abandono em dois serviços públicos de ...
Raquel Regina de Freitas Magalhães Gomes, Carla Jorge Machado, Francisco de Assis Acurcio, Mark Drew Crosland Guimarães   +3 more
doaj   +1 more source

Global Health Implications of US Exit From WHO and Suspension of Aid

Public Health Challenges, Volume 5, Issue 2, June 2026.
Kenneth Chukwuebuka Egwu, Maryam Abdulkarim, Molly Unoh Ogbodum, Yusuff Adebayo Adebisi, Dukanwojo Beulah Suleman, Don Eliseo Lucero‐Prisno III   +5 more
wiley   +1 more source

Terapia antirretroviral altamente eficaz para infecção pelo vírus da imunodeficiência humana aumenta a rigidez aórtica

Arquivos Brasileiros de Cardiologia
FUNDAMENTO: Sabe-se que a terapia antirretroviral altamente potente para Aids reconhecida aumenta o risco cardiovascular, mas os efeitos dos agentes antirretrovirais de acordo com o gênero ainda são desconhecidos.
Margareth Eira, Isabela M. Bensenor, Egidio Lima Dorea, Roberto Sá Cunha, José Geraldo Mill, Paulo A. Lotufo   +5 more
doaj